The length of the third stage of labor and the risk of postpartum hemorrhage

Obstetrics and Gynecology

Volumn 105, Issue 2, 2005, Pages 290-293

  Magann, Everett F ^b   Evans, Sharon ^b   Chauhan, Suneet P ^b   Lanneau, Grainger ^b   Fisk, Andrea D ^b   Morrison, John C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HUMAN; LABOR; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RISK FACTOR; VAGINAL DELIVERY;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INCIDENCE; LABOR STAGE, THIRD; LABOR, OBSTETRIC; LOGISTIC MODELS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 13644271573     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000151993.83276.70     Document Type: Article

References (13)

1. Dombrowski MP, Bottoms SF, Saleh AA, Hurd WW, Romero R. Third stage of labor: analysis of duration and clinical practice. Am J Obstet Gynecol 1995;172:1279-84.
2. Gulmezoglu AM, Villar J, Ngoc NN, Piaggio G, Carroli G, Adetoro L, et al.; WHO Collaborative Group To Evaluate Misoprostol in the Management of the Third Stage of Labour. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-95.
3. Bugalho A, Daniel A, Faundes A, Cunha M. Misoprostol for prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2001;73:1-6.
4. Combs CA, Laros RK. Prolonged third stage of labor: morbidity and risk factors. Obstet Gynecol 1991;77:863-7.
5. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour (Cochrane Review). In: The Cochrane Library, Issue 3, 2000. Oxford: Update Software.
6. Rogers J, Wood J, McCandlish R, Ayers S, Truesdale A, Elbourne D. Active versus expectant management of the third stage of labour: the Hinchingbrooke randomized controlled trial. Lancet 1998;351:693-99.
7. Jackson KW, Allbert JR, Schemmer GK, Elliot M, Humphrey A, Taylor J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 2001;185:873-7.
8. Gerstenfeld TS, Wing DA. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. Am J Obstet Gynecol 2001;185:878-82.
9. McDonald S, Prendiville WJ, Elbourne D. Prophylactic syntometrine versus oxytocin for delivery of the placenta. (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software.
10. Kundodya TW, Majoka F, Rusqkaniko S. Misoprostol versus oxytocin in the third stage of labor. Int J Gynaecol Obstet 2001;75:235-41.
11. Combs CA, Murphy EL, Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69-76.
12. Magann EF, Dodson MR, Albert JR, McCurdy CM Jr., Martin RW, Morrison JC. Blood loss at time of cesarean section by method of placental removal and exteriorization versus in situ repair of the uterine incision. Surg Gynecol Obstet 1993;177:389-92.
13. Revised 1990 estimates of maternal mortality: a new approach by WHO and UNICEF. Geneva: World Health Organization; 2000.